Evaluation of optimal psoriasis assessment tool (OPAT) incorporating both clinical and patient-reported outcomes for treatment of moderate-to-severe plaque psoriasis

被引:0
|
作者
Leonardi, C. [2 ]
See, K. [1 ]
Burge, R. [1 ]
Gallo, G. [1 ]
McKean-Matthews, M. [3 ]
Goldblum, O. [1 ]
Wu, J. [4 ]
机构
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Cent Dermatol, St Louis, MO USA
[3] Syneos Hlth, Raleigh, NC USA
[4] Dermatol Res & Educ Fdn, Irvine, CA USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
541
引用
收藏
页码:S93 / S93
页数:1
相关论文
共 50 条
  • [1] Evaluation of optimal psoriasis assessment tool incorporating both clinical measures and patient-reported outcomes for the treatment of moderate-to-severe plaque psoriasis
    Leonardi, Craig
    See, Kyoungah
    Burge, Russel
    Gallo, Gaia
    McKean-Matthews, Missy
    Goldblum, Orin
    Wu, Jashin J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB208 - AB208
  • [2] Patient-reported treatment satisfaction in moderate to severe plaque psoriasis
    Brenneman, Susan
    Carter, Chureen
    Essoi, Breanna
    Farahi, Kamyar
    Johnson, Michael P.
    Lee, Seina
    Olson, William
    Zhang, Mingliang
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB242 - AB242
  • [3] Patient-reported Outcomes and Clinical Response in Patients with Moderate-to-severe Plaque Psoriasis Treated with Tonsillectomy: A Randomized Controlled Trial
    Thorleifsdottir, Ragna Hlin
    Sigurdardottir, Sigrun Laufey
    Sigurgeirsson, Bardur
    Olafsson, Jon Hjaltalin
    Sigurdsson, Martin Ingi
    Petersen, Hannes
    Gudjonsson, Johann Eli
    Johnston, Andrew
    Valdimarsson, Helgi
    ACTA DERMATO-VENEREOLOGICA, 2017, 97 (03) : 340 - 345
  • [4] Impact of secukinumab on patient-reported outcomes in moderate to severe plaque psoriasis: a review of clinical studies
    Galluzzo, Marco
    Talamonti, Marina
    Manfreda, Valeria
    Silvaggio, Dionisio
    Tartaglia, Chiara
    Roberto, Denis
    Campione, Elena
    Bianchi, Luca
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (02) : 191 - 200
  • [5] Treatment of moderate-to-severe plaque psoriasis
    Salgo, R.
    Thaci, D.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2009, 144 (06): : 701 - 711
  • [6] Characterization of Patient-reported Outcomes in moderate to severe Psoriasis
    Radtke, M. A.
    Schmitt-Rau, K. H.
    Krenzer, S.
    Augustin, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 126 - 126
  • [7] Patient-reported Outcomes During Treatment in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Study
    Loft, Nikolai Dyrberg
    Egeberg, Alexander
    Rasmussen, Mads Kirchheiner
    Bryld, Lars Erik
    Gniadecki, Robert
    Dam, Tomas Norman
    Iversen, Lars
    Skov, Lone
    ACTA DERMATO-VENEREOLOGICA, 2019, 99 (13) : 1224 - 1230
  • [8] Characterization of Patient-Reported Outcomes in Moderate to Severe Psoriasis
    Krenzer, Stefanie
    Radtke, Marc
    Schmitt-Rau, Karlheinz
    Augustin, Matthias
    DERMATOLOGY, 2011, 223 (01) : 80 - 86
  • [9] Evaluation of Patient-Reported Outcomes With Etanercept in Moderate to Severe Plaque Psoriasis Patients After Therapy With Apremilast
    Bagel, Jerry
    Stolshek, Bradley S.
    Yang, Yue
    Kricorian, Gregory
    Kircik, Leon H.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2020, 19 (04) : 378 - 383
  • [10] Development of a patient-reported outcome questionnaire for use in adults with moderate-to-severe plaque psoriasis: The Psoriasis Symptoms and Signs Diary
    Feldman, Steven R.
    Mathias, Susan D.
    Schenkel, Brad
    Colwell, Hilary H.
    McQuarrie, Kelly
    Randazzo, Bruce
    Han, Chenglong
    JOURNAL OF DERMATOLOGY DERMATOLOGIC SURGERY-JDDS, 2016, 20 (01): : 19 - 26